tecelra
Generic: afamitresgene autoleucel·Code: ADP-A2M4
tecelra: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Adaptimmune Therapeutics PLC (ADAP) | Approved |
Get deeper analysis on tecelra
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis